Source: Breathe 2008; 4: 342-344
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D.E. O'Donnell. Bronchodiator therapy in COPD: physiological effects. Breathe 2008; 4: 342-344

Member's Comments

No comment yet.

Related content which might interest you: COPD and asthma: the effect of glucocorticosteroid therapy on tolerance to physical activity Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Do different combinations of bronchodilator therapies have different effects on health status in patients with COPD? Source: Eur Respir J 2003; 22: Suppl. 45, 52s Year: 2003 Differential effects of acute correction of hypoxemia in COPD patients on exercise performance: physiological mechanisms Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005 Additive effect of targeted lung denervation plus drug in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Treating systemic effects of COPD Source: Annual Congress 2012 - PG9 Progress on the treatment of COPD Year: 2012 Treating systemic effects of COPD Source: Annual Congress 2009 - Emerging trends in the therapy of COPD Year: 2009 The effect of statin therapy in patients with chronic obstructive airway disease Source: International Congress 2015 – COPD: notable points Year: 2015 Does azithromycin-prednisolone combination therapy have additive effects than single therapy in patients with persistent asthma? Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009 Addition of theophylline to standard inhalatory therapy in patients with stable COPD: effects on exercise tolerance Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006 Looking back to go forward: adherence to inhaled therapy before biologic therapy in severe asthma Source: Eur Respir J, 55 (5) 2000954; 10.1183/13993003.00954-2020 Year: 2020 Fructosamine-3-Kinase: A molecular link between COPD and diabetes regulating carbonyl stress and the impact of metformin treatment Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 The effects of adding in erdosteine on the routine bronchodilator therapy in moderate and severe COPD patients Source: Annual Congress 2006 - COPD therapy Year: 2006 Comparison of protective effect of bronchodilators in COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 The adherence to inhaled drugs in COPD patients: Effect on survival Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Effect of indacaterol/glycopyrronium versus salmeterol/fluticasone on hypothalamic pituitary-adrenal axis function in moderate-to-very severe COPD patients: Results from the FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 The effect of combined β2-agonist and anticholinergic inhaled therapy in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004 Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Where current pharmacological therapies fall short in COPD: symptom control is not enough Source: Eur Respir Rev 2007; 16: 98-104 Year: 2007 Treatment of COPD: from pharmacological to instrumental therapies Source: Eur Respir Rev 2009; 19: 7-23 Year: 2010